| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Willard H Dere is Director at BMRN, with reported holdings spanning 3 companies. Willard H Dere's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $2.6M at current prices.
Willard H Dere's largest disclosed position is in BMRN as Director, worth about $2.6M. The BMRN filings lean toward selling, a net 4,430 shares.
Willard H Dere has 43 Form 4 filings on record from July 2016 to July 2026, across 4 companies: Director at Seres Therapeutics (MCRB), 2017–2026; Director at Metagenomi Therapeutics (MGX), 2024–2026; Director at BioMarin Pharmaceutical (BMRN), 2016–2026, and 1 more.
The 58 reported transactions were 27 option or other derivative awards, 17 stock awards, 12 dispositions back to the company and 1 tender, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $548K.
The only open-market sale was 4,430 shares of BMRN at an average $123.61 on June 26, 2020, about $548K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 26, 2020 | BMRN Biomarin Pharmaceutical Inc | Director | Sell | 4,430 | $123.61 | $547,592.30 | -25.0% |